Zamanillo Campos, RocíoSerrano-Ripoll, Maria JesusTaltavull Aparicio, Joana MariaGervilla Garcia, ElenaRipoll Amengual, JoanaFiol-deRoque, Maria AntoniaBoylan, Anne-MarieRicci-Cabello, Ignacio2024-10-042024-10-042022-02-08Zamanillo-Campos R, Serrano-Ripoll MJ, Taltavull-Aparicio JM, Gervilla-García E, Ripoll J, Fiol-deRoque MA, et al. Patients Views on the Design of DiabeText, a New mHealth Intervention to Improve Adherence to Oral Antidiabetes Medication in Spain: A Qualitative Study. Int J Environ Res Public Health. 2022 Feb 8;19(3).http://hdl.handle.net/20.500.13003/18469https://hdl.handle.net/20.500.12105/23493Background: Type 2 Diabetes Mellitus (T2DM) is a long-term condition affecting around 10% of people worldwide. This study aimed to explore T2DM patients' views on DiabeText, a new text messaging intervention to be developed to support adherence to diabetes medication. Methods: A total of four focus groups were conducted with a purposive sample of people with T2DM (n = 34). The data were analysed by multiple researchers independently, and coded using thematic analysis. Results: There were two main themes that emerged: (1) "patients' perspectives on unmet needs for diabetes self-management", and (2) "acceptability and perceived utility of DiabeText". The patients identified a number of barriers for diabetes self-management, including lack of appropriate information and support with diet and physical activity. Support for medication-taking was not perceived as urgently needed, although several barriers were identified (eating outside, traveling, polymedication, dispensation at the pharmacy). The participants anticipated that the proposed intervention would present high levels of patient acceptability and perceived utility as long as its content addresses the barriers that were identified, and includes specific features (short and clear messages, and personalized information). Conclusion: The proposed intervention has the potential to be well accepted and perceived as useful by T2DM patients who require support not only in terms of medication-taking, but more prominently of lifestyle behaviour.enghttp://creativecommons.org/licenses/by/4.0/Diabetes Mellitus, Type 2Text MessagingSpainMedication AdherenceTelemedicineHumansQualitative Researchresearch articleAttribution 4.0 International3516292119310.3390/ijerph190319021660-4601International journal of environmental research and public healthopen accessCumplimiento de la MedicaciónHumanosTelemedicinaDiabetes Mellitus Tipo 2Investigación CualitativaEnvío de Mensajes de TextoEspaña2-s2.0-85124680130756142600001L2015581428